Correspondence
HER2-low-positive breast cancer from four neoadjuvant clinical trials

https://doi.org/10.1016/S1470-2045(21)00456-3Get rights and content

References (5)

  • P Tarantino et al.

    HER2-low breast cancer: pathological and clinical landscape

    J Clin Oncol

    (2020)
  • C Denkert et al.

    Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

    Lancet Oncol

    (2021)
There are more references available in the full text version of this article.
View full text